Chemistry:Fluminorex
From HandWiki
Short description: Chemical compound
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
Chemical and physical data | |
Formula | C10H9F3N2O |
Molar mass | 230.190 g·mol−1 |
3D model (JSmol) | |
Chirality | Racemic mixture |
| |
| |
(verify) |
Fluminorex is a centrally acting sympathomimetic which is related to other drugs such as aminorex and pemoline. It was developed as an appetite suppressant by McNeil Laboratories in the 1950s.[1][2]
Synthesis
Error creating thumbnail: Unable to save thumbnail to destination
2-amino-1-[4-(trifluoromethyl)phenyl]ethanol [776-02-3] (1) cyanogen bromide [506-68-3] (2)
See also
- 4'-Fluoro-4-methylaminorex
- 4-Methylaminorex
- Aminorex
- Clominorex
- Cyclazodone
- Fenozolone
- Pemoline
- Thozalinone
References
- ↑ US Patent 3278382 - 2-amino-5-aryloxazoline compositions and methods of using same
- ↑ "DARK Classics in Chemical Neuroscience: Aminorex Analogues". ACS Chemical Neuroscience 9 (10): 2484–2502. October 2018. doi:10.1021/acschemneuro.8b00415. PMID 30269490.
- ↑ "2-amino-5-Aryl-2-oxazolines. Potent New Anorectic Agents". Journal of Medicinal Chemistry 6 (3): 266–272. May 1963. doi:10.1021/jm00339a011. PMID 14185981.
- ↑ Poos George Ireland, U.S. Patent 3,278,382 (1966 to Janssen Pharmaceuticals Inc).
0.00 (0 votes)
|